Detalhe da pesquisa
1.
Switching from combination therapy with entecavir hydrate plus tenofovir alafenamide fumarate to tenofovir alafenamide fumarate monotherapy in patients with chronic hepatitis B based on nucleotide sequences of hepatitis B virus pregenome RNA.
Hepatol Res
; 2024 Mar 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38517681
2.
Significance of portal venous blood flow as a factor to determine liver function in patients with decompensated cirrhosis due to hepatitis C virus infection following achievement of sustained viral response by sofosbuvir plus velpatasvir.
Hepatol Res
; 53(9): 815-828, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37243512
3.
Significance of furosemide in patients with cirrhosis treated with or without zinc acetate hydrate supplementation.
Hepatol Res
; 52(5): 449-461, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35113468
4.
Significance of switching of the nucleos(t)ide analog used to treat Japanese patients with chronic hepatitis B virus infection from entecavir to tenofovir alafenamide fumarate.
J Med Virol
; 92(3): 329-338, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31777965
5.
Furosemide as a factor to deteriorate therapeutic efficacy of tolvaptan in patients with decompensated cirrhosis.
Hepatol Res
; 50(12): 1355-1364, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-32886950
6.
Furosemide as a factor to deteriorate therapeutic efficacy of rifaximin in patients with decompensated cirrhosis.
Hepatol Res
; 50(11): 1264-1274, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-32833292
7.
Involvement of portosystemic shunts in impaired improvement of liver function after direct-acting antiviral therapies in cirrhotic patients with hepatitis C virus.
Hepatol Res
; 50(4): 512-523, 2020 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-31837277
8.
A case of genotype-3b hepatitis C virus in which the whole genome was successfully analyzed using third-generation nanopore sequencing.
Hepatol Res
; 49(9): 1083-1087, 2019 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-30924272
9.
Chronic hepatitis caused by hepatitis C virus showing a discrepancy between serogroup and genotype because of intergenotypic 2b/1b recombination: A pitfall in antiviral therapy with direct-acting antivirals.
Hepatol Res
; 48(3): E372-E378, 2018 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-28872737
10.
Retreatment with sofosbuvir/ledipasvir with or without lead-in interferon-ß injections in patients infected with genotype 1b hepatitis C virus after unsuccessful daclatasvir/asunaprevir therapy.
Hepatol Res
; 48(4): 233-243, 2018 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-28884930
11.
"Reversi-type virologic failure" involved in the development of non-structural protein 5A resistance-associated variants (RAVs) in patients with genotype 1b hepatitis C carrying no signature RAVs at baseline.
Hepatol Res
; 47(13): 1397-1407, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-28239934
12.
Development of rare resistance-associated variants that are extremely tolerant against NS5A inhibitors during daclatasvir/asunaprevir therapy by a two-hit mechanism.
Hepatol Res
; 46(12): 1234-1246, 2016 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26878268
13.
Significance of switching of the nucleos(t)ide analog used to treat Japanese patients with chronic hepatitis B virus infection from entecavir to tenofovir alafenamide fumarate.
J Med Virol
; 92(8): 1370, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32677098
14.
Novel hepatitis B virus strain developing due to recombination between genotypes H and B strains isolated from a Japanese patient.
Hepatol Res
; 44(11): 1130-1141, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24020990
15.
Superiority of tenofovir alafenamide fumarate over entecavir for serum HBsAg level reduction in patients with chronic HBV infection: A 144-week outcome study after switching of the nucleos(t)ide analog.
PLoS One
; 17(2): e0262764, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35180213
16.
NS5A-P32 deletion as a factor involved in virologic failure in patients receiving glecaprevir and pibrentasvir.
J Gastroenterol
; 54(5): 459-470, 2019 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-30612205
17.
Serum asunaprevir concentrations showing correlation with the extent of liver fibrosis as a factor inducing liver injuries in patients with genotype-1b hepatitis C virus receiving daclatasvir plus asunaprevir therapy.
PLoS One
; 13(10): e0205600, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30308053
18.
Significance of NS5B Substitutions in Genotype 1b Hepatitis C Virus Evaluated by Bioinformatics Analysis.
Sci Rep
; 8(1): 8818, 2018 06 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-29892096
19.
Significance of variants associated with resistance to NS5A inhibitors in Japanese patients with genotype 1b hepatitis C virus infection as evaluated using cycling-probe real-time PCR combined with direct sequencing.
J Gastroenterol
; 51(3): 260-70, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26245700
20.
Purification, crystallization and preliminary X-ray analysis of a hexameric beta-glucosidase from wheat.
Acta Crystallogr Sect F Struct Biol Cryst Commun
; 61(Pt 9): 864-6, 2005 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-16511181